Controlled-release delivery system for the α-MSH analog Melanotan-I using poloxamer 407

Journal of Pharmaceutical Sciences

Volumn 85, Issue 9, 1996, Pages 915-919

  Bhardwaj, Renu ^a   Blanchard, James ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; HYDROXYPROPYLMETHYLCELLULOSE; INTERMEDIN DERIVATIVE; METHYLCELLULOSE; POLOXAMER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; GUINEA PIG; INTRAPERITONEAL DRUG ADMINISTRATION; MELANOGENESIS; NONHUMAN; PHARMACEUTICS; SKIN CANCER; SUSTAINED RELEASE PREPARATION;

EID: 0029761794     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960097g     Document Type: Article

References (23)

1. Sawyer, T. K.; Sanfillippo, P. J.; Hruby, V. J.; Engel, E. H.; Heward, C. B.; B. Burnett, B.; Hadley, M. E. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 5754.
2. Hadley, M. E.; Marwan, M. M.; Al-Obeidi, F.; Hruby, V. J.; Castrucci, A. M. L. Pigm. Cell Res. 1989, 2, 478.
3. Tomlinson, E.; Davis, S. S.; Illum, L. Delivery Systems for Peptide Drugs, Plenum Press: New York, 1986; pp 1-125.
4. Ugwu, S. O.; Blanchard, J.; Dorr, R. T.; Levine, N.; Brooks, C.; Hadley, M. E.; Aickin, M.; Hruby, V. J. Biopharm. Drug. Dispos., submitted.
5. Schmolka, I. R. In Polymers for Controlled Drug Delivery; Tarcha, P. J., Ed.; CRC Press: Boca Raton, FL, 1991; Chapter 10, pp 189-214.
6. Wang, P.; Johnston, T. P. J. Appl. Polym. Sci. 1991, 43, 283-292.
7. BASF Corporation Pluronic® and Tetronic® Surfactants; BASF Corporation: Parsippany, NJ, 1989, pp 1-29.
8. Schmolka, I. R. Artificial skin I. J. Biomed. Mater. Res. 1972, 6, 571-582.
9. Johnston, T. P.; Miller, S. C. J. Parenter. Sci. Technol. 1985, 39, 83-88.
10. Fults, K. A.; Johnston, T. P. J. Parenter. Sci. Technol. 1990, 44, 58-65.
11. Pec, E. A.; Wout, Z.; Johnston, T. P. J. Pharm. Sci. 1992, 18, 626-630.
12. Johnston, T. P.; Punjabi, M. A.; Froelich, C. Pharm. Res. 1992, 9, 425-434.
13. Johnston, T. P.; Miller, S. C. J. Parenter. Sci. Technol. 1989, 43, 279-286.
14. Guzman, M.; Garcia, F. F.; Molpeceres, J.; Aberturas, M. R. Int. J. Pharm. 1992, 80, 119-127.
15. Desai, S.; Blanchard, J. Unpublished results.
16. Surendran, N.; Ugwu, S. O.; Sterling, E. J.; Blanchard, J. J. Chromatogr. 1995, 620, 235-242.
17. Dumortier, G.; Grossiord, J. L.; Zuber, M.; Couarraze, G.; Chaumeil, J. C. Drug Dev. Ind. Pharm. 1991, 17, 1255-1265.
18. Kreutzfeld, K. L.; Bagnara, J. T. Pigm. Cell Res. 1989, 2, 65-69.
19. Chen-Chow, P. C.; Frank, S. G. Int. J. Pharm. 1981, 8, 88-99.
20. Gilbert, J. C.; Hadgraft, J.; Bye, A.; Brookes, L. J. Int. J. Pharm. 1986, 32, 223-238.
21. Ford, J. L.; Rubinstein, M. H.; McCaul, F.; Hogan, J. E.; Edgar, P. J. Int. J. Pharm. 1987, 40, 223-234.
22. Urtti, A.; Juslin, M.; Minalainen, O. Int. J. Pharm. 1985, 25, 165-178.
23. Personal communication, Alcon Laboratories, Fort Worth, TX.